As of December 2024, Oryzon Genomics has a market cap of $95.90M. This makes Oryzon Genomics the world's 20318th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $118.93M | 0.11% |
2023 | $118.81M | -23.87% |
2022 | $156.06M | -8.15% |
2021 | $169.90M | -22.86% |
2020 | $220.25M | 25.90% |
2019 | $174.94M | 28.41% |
2018 | $136.24M | -17.21% |
2017 | $164.55M | -39.87% |
2016 | $273.67M | 20.81% |
2015 | $226.54M | - |